Evidence map›Paper›PMID 26424477›Full record

Trial reportNutrition journal2015

Effects of different arachidonic acid supplementation on psychomotor development in very preterm infants; a randomized controlled trial.

Ayham Alshweki, Alejandro Pérez Muñuzuri, Ana M Baña, Ma José de Castro, Fernando Andrade, Luís Aldamiz-Echevarría, Miguel Sáenz de Pipaón, José M Fraga, María L Couce

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrition journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02503020 (Effects of Different Arachidonic Acid Supplementation on Psychomotor Development in Very Preterm Infants, a Randomized Controlled Trial), which is not on this map. Cited by 32 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 5 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02503020 phase2completednot on this map

Effects of Different Arachidonic Acid Supplementation on Psychomotor Development in Very Preterm Infants, a Randomized Controlled Trial

TypeinterventionalSponsorHealth Research Institute of SantiagoRan2011 to 2015Enrolled45ConditionsImpaired Psychomotor DevelopmentArmsPreterm infants formula A, Preterm infants formula B
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 5 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Longchain polyunsaturated fatty acid supplementation in preterm infants.The Cochrane database of systematic reviews · 2016
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. A ComparativeMolecules (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Preterm nutrition and neurodevelopmental outcomes.World journal of methodology · 2021
    Review
  20. Parenteral lipid emulsions in the preterm infant: current issues and controversies.Archives of disease in childhood. Fetal and neonatal edition · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Ayham AlshwekiNeonatology Unit, Department of Paediatrics, University Clinical Hospital of Santiago de Compostela. IDIS, CIBERER, Travesia Choupana, 15706, Santiago de Compostela, Spain. drayham@live.com.
Alejandro Pérez MuñuzuriNeonatology Unit, Department of Paediatrics, University Clinical Hospital of Santiago de Compostela. IDIS, CIBERER, Travesia Choupana, 15706, Santiago de Compostela, Spain. apmunuzuri@yahoo.es.
Ana M BañaNeonatology Unit, Department of Paediatrics, University Clinical Hospital of Santiago de Compostela. IDIS, CIBERER, Travesia Choupana, 15706, Santiago de Compostela, Spain. anamariabana@gmail.com.
Ma José de CastroNeonatology Unit, Department of Paediatrics, University Clinical Hospital of Santiago de Compostela. IDIS, CIBERER, Travesia Choupana, 15706, Santiago de Compostela, Spain. mj.decastrol@gmail.com.
Fernando AndradeMotabolism Group, BioCruces Health Research Institute, CIBER of Rare Diseases (CIBERER), Plaza de Cruces 12, 48903 Baracaldo, Vizcaya, Spain. fernando.andradelodeiro@osakidetza.net.
Luís Aldamiz-EchevarríaMotabolism Group, BioCruces Health Research Institute, CIBER of Rare Diseases (CIBERER), Plaza de Cruces 12, 48903 Baracaldo, Vizcaya, Spain. luisjose.aldamiz-echevarazuara@osakidetza.net.
Miguel Sáenz de PipaónNeonatology Unit, Department of Paediatrics, La Paz University Clinical Hospital, P de la Castellana 261, 28064, Madrid, Spain. miguel.saenz@salud.madrid.org.
José M FragaNeonatology Unit, Department of Paediatrics, University Clinical Hospital of Santiago de Compostela. IDIS, CIBERER, Travesia Choupana, 15706, Santiago de Compostela, Spain. jose.maria.fraga.bermudez@sergas.es.
María L CouceNeonatology Unit, Department of Paediatrics, University Clinical Hospital of Santiago de Compostela. IDIS, CIBERER, Travesia Choupana, 15706, Santiago de Compostela, Spain. maria.luz.couce.pico@sergas.es.
Instituto de Investigación Sanitaria de Santiago · ESBioCruces Health research Institute · ESCentre for Biomedical Network Research on Rare Diseases · ESHospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsNutritional supplementation with polyunsaturated fatty acids is important in preterm infants neurodevelopment, but it is not known if the omega-6/omega-3 ratio affects this process. This study was designed to determine the effects of a balanced contribution of arachidonic acid in very preterm newborns fed with formula milk.

methodsThis was a randomized trial, in which newborns <1500 g and/or <32 weeks gestational age were assigned to one of two groups, based on the milk formula they would receive during the first year of life. Initially, 60 newborns entered the study, but ultimately, group A was composed of 24 newborns, who were given formula milk with an ω-6/ω-3 ratio of 2/1, and Group B was composed of 21 newborns, given formula milk with an ω-6/ω-3 ratio of 1/1. The infants were followed up for two years: growth, visual-evoked potentials, brainstem auditory-evoked potentials, and plasma fatty acids were periodically measured, and psychomotor development was assessed using the Brunet Lézine scale at 24 months corrected age. A control group, for comparison of Brunet Lézine score, was made up of 25 newborns from the SEN1500 project, who were fed exclusively with breast milk.

resultsAt 12 months, arachidonic acid values were significantly higher in group A than in group B (6.95 ± 1.55% vs. 4.55 ± 0.78%), as were polyunsaturated fatty acids (41.02 ± 2.09% vs. 38.08 ± 2.32%) achieved a higher average. Group A achieved a higher average Brunet Lézine score at 24 months than group B (99.9 ± 9 vs. 90.8 ± 11, p =0.028). The Brunet Lézine results from group A were compared with the control group results, with very similar scores registered between the two groups (99.9 ± 9 vs. 100.5 ± 7). There were no significant differences in growth or evoked potentials between the two formula groups.

conclusionsVery preterm infants who received formula with an ω-6/ω-3 ratio of 2/1 had higher blood levels of essential fatty acids during the first year of life, and better psychomotor development, compared with very preterm newborns who consumed formula with an ω-6/ω-3 of 1/1. Therefore, formula milk with an arachidonic acid quantity double that of docosahexaenoic acid should be considered for feeding very preterm infants.

trial registrationClinicalTrials.gov Identifier NCT02503020.

Indexed as

Infant Nutritional Physiological PhenomenaArachidonic AcidChild DevelopmentChild, PreschoolDietary SupplementsDouble-Blind MethodFatty AcidsFatty Acids, Omega-6FemaleFollow-Up StudiesGestational AgeHumansInfantInfant FormulaInfant, NewbornInfant, PrematureArachidonic AcidFatty AcidsFatty Acids, Omega-6

Identifiers

PMID26424477
PMCPMC4590272
OpenAlexW2170881335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.